{"entity":{"type":"insider","cik":"0001434095","url":"/insider/0001434095","json_url":"/insider/0001434095.json","name":"Tessmer James F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2016-05-23","last":"2021-03-16","span_basis":"filed_date"},"name_variants":[{"name":"Tessmer James F","source":"filing","n_filings":5,"first_seen":"2016-05-23","last_seen":"2021-03-16"}],"transactions":[{"id":4853364,"accession":"0001127602-21-010892","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-010892","line_url":"/filing/0001127602-21-010892","is_derivative":false,"issuer_cik":"0001062822","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001062822","owner_cik":"0001434095","owner_name":"Tessmer James F","owner_display_name":"Tessmer James F","owner_url":"/insider/0001434095","role":"Officer (VP, Finance & Accounting)","role_mark":"O","role_mark_label":"Officer (VP, Finance & Accounting)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance & Accounting","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22912.0,"shares_display":"22,912","price_per_share":6.915141480446928,"price_display":"6.92","price_state":"stated","total_value":158439.7216,"total_display":"158,439.72","total_whole":"158,440","shares_owned_after":71766.0,"shares_owned_after_display":"71,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-16","scope":"insider","n_lines":2},{"id":8563375,"accession":"0001127602-19-025869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-025869","line_url":"/filing/0001127602-19-025869#line-1","is_derivative":false,"issuer_cik":"0001062822","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001062822","owner_cik":"0001434095","owner_name":"Tessmer James F","owner_display_name":"Tessmer James F","owner_url":"/insider/0001434095","role":"Officer (VP, Finance & Accounting)","role_mark":"O","role_mark_label":"Officer (VP, Finance & Accounting)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance & Accounting","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":11400.0,"total_display":"11,400.00","total_whole":"11,400","shares_owned_after":43368.0,"shares_owned_after_display":"43,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-02","scope":"insider"},{"id":6386680,"accession":"0001127602-18-020694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-020694","line_url":"/filing/0001127602-18-020694#line-2","is_derivative":false,"issuer_cik":"0001062822","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001062822","owner_cik":"0001434095","owner_name":"Tessmer James F","owner_display_name":"Tessmer James F","owner_url":"/insider/0001434095","role":"Officer (VP, Finance & Accounting)","role_mark":"O","role_mark_label":"Officer (VP, Finance & Accounting)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance & Accounting","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.9076,"price_display":"12.91","price_state":"stated","total_value":129076.0,"total_display":"129,076.00","total_whole":"129,076","shares_owned_after":25643.0,"shares_owned_after_display":"25,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":2429712,"accession":"0001127602-16-054955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-16-054955","line_url":"/filing/0001127602-16-054955#line-2","is_derivative":false,"issuer_cik":"0001062822","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001062822","owner_cik":"0001434095","owner_name":"Tessmer James F","owner_display_name":"Tessmer James F","owner_url":"/insider/0001434095","role":"Officer (VP, Finance & Accounting)","role_mark":"O","role_mark_label":"Officer (VP, Finance & Accounting)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance & Accounting","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":15946.0,"shares_owned_after_display":"15,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":3324244,"accession":"0001127602-16-053152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-16-053152","line_url":"/filing/0001127602-16-053152#line-2","is_derivative":false,"issuer_cik":"0001062822","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001062822","owner_cik":"0001434095","owner_name":"Tessmer James F","owner_display_name":"Tessmer James F","owner_url":"/insider/0001434095","role":"Officer (VP, Finance & Accounting)","role_mark":"O","role_mark_label":"Officer (VP, Finance & Accounting)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance & Accounting","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":78000.0,"total_display":"78,000.00","total_whole":"78,000","shares_owned_after":15946.0,"shares_owned_after_display":"15,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001062822","name":"LEXICON PHARMACEUTICALS, INC.","url":"/issuer/0001062822","role":"Officer (VP, Finance & Accounting)","n_filings":5,"first_seen":"2016-05-23","last_seen":"2021-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001434095","retrieved_at":"2026-08-22T21:47:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}